As of 2025-12-15, the Relative Valuation of Resmed Inc (RMD) is 350.47 USD. This relative valuation is based on P/E multiples. With the latest stock price at 252.27 USD, the upside of Resmed Inc based on Relative Valuation is 38.9%.
The range of the Relative Valuation is 335.01 - 377.08 USD.
| Range | Selected | |
| Trailing P/E multiples | 35.6x - 38.3x | 36.0x |
| Forward P/E multiples | 31.0x - 33.9x | 32.0x |
| Fair Price | 335.01 - 377.08 | 350.47 |
| Upside | 32.8% - 49.5% | 38.9% |
| Date | P/E |
| 2025-12-12 | 25.61 |
| 2025-12-11 | 25.62 |
| 2025-12-10 | 25.53 |
| 2025-12-09 | 25.03 |
| 2025-12-08 | 25.38 |
| 2025-12-05 | 26.04 |
| 2025-12-04 | 25.53 |
| 2025-12-03 | 25.53 |
| 2025-12-02 | 25.47 |
| 2025-12-01 | 25.21 |
| 2025-11-28 | 25.97 |
| 2025-11-26 | 25.89 |
| 2025-11-25 | 25.97 |
| 2025-11-24 | 25.43 |
| 2025-11-21 | 25.46 |
| 2025-11-20 | 24.76 |
| 2025-11-19 | 24.87 |
| 2025-11-18 | 25.00 |
| 2025-11-17 | 24.84 |
| 2025-11-14 | 24.82 |
| 2025-11-13 | 25.59 |
| 2025-11-12 | 25.67 |
| 2025-11-11 | 25.63 |
| 2025-11-10 | 25.39 |
| 2025-11-07 | 25.53 |
| 2025-11-06 | 25.34 |
| 2025-11-05 | 24.89 |
| 2025-11-04 | 25.01 |
| 2025-11-03 | 25.27 |
| 2025-10-31 | 25.06 |
| 2025-10-30 | 25.61 |
| 2025-10-29 | 25.75 |
| 2025-10-28 | 26.05 |
| 2025-10-27 | 26.31 |
| 2025-10-24 | 26.34 |
| 2025-10-23 | 26.93 |
| 2025-10-22 | 27.05 |
| 2025-10-21 | 27.23 |
| 2025-10-20 | 27.55 |
| 2025-10-17 | 27.22 |
| 2025-10-16 | 27.41 |
| 2025-10-15 | 27.38 |
| 2025-10-14 | 27.42 |
| 2025-10-13 | 27.71 |
| 2025-10-10 | 27.61 |
| 2025-10-09 | 28.21 |
| 2025-10-08 | 28.66 |
| 2025-10-07 | 28.76 |
| 2025-10-06 | 28.56 |
| 2025-10-03 | 28.28 |